| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1635* | 2021 |
| “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and … DSP Tan, C Rothermundt, K Thomas, E Bancroft, R Eeles, S Shanley, ... Journal of Clinical Oncology 26 (34), 5530-5536, 2008 | 561 | 2008 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 444* | 2021 |
| Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer E Castro, C Goh, D Leongamornlert, E Saunders, M Tymrakiewicz, ... European urology 68 (2), 186-193, 2015 | 367 | 2015 |
| Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer E Castro, C Goh, D Leongamornlert, E Saunders, M Tymrakiewicz, ... European urology 68 (2), 186-193, 2015 | 367 | 2015 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| The genetic epidemiology of prostate cancer and its clinical implications R Eeles, C Goh, E Castro, E Bancroft, M Guy, AAA Olama, D Easton, ... Nature reviews Urology 11 (1), 18-31, 2014 | 316 | 2014 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ... European urology 66 (3), 489-499, 2014 | 290 | 2014 |
| Mutational signatures of ionizing radiation in second malignancies S Behjati, G Gundem, DC Wedge, ND Roberts, PS Tarpey, SL Cooke, ... Nature communications 7 (1), 1-8, 2016 | 262 | 2016 |
| Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations CA Shu, MC Pike, AR Jotwani, TM Friebel, RA Soslow, DA Levine, ... JAMA oncology 2 (11), 1434-1440, 2016 | 244 | 2016 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 233 | 2022 |
| Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets DC Wedge, G Gundem, T Mitchell, DJ Woodcock, I Martincorena, M Ghori, ... Nature genetics 50 (5), 682-692, 2018 | 232 | 2018 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ... European urology 76 (6), 831-842, 2019 | 210 | 2019 |
| Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study T Nyberg, D Frost, D Barrowdale, DG Evans, E Bancroft, J Adlard, ... European urology 77 (1), 24-35, 2020 | 199 | 2020 |
| Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype A Mitra, C Fisher, CS Foster, C Jameson, Y Barbachanno, J Bartlett, ... British journal of cancer 98 (2), 502-507, 2008 | 195 | 2008 |
| Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the … AV Mitra, EK Bancroft, Y Barbachano, EC Page, CS Foster, C Jameson, ... BJU international 107 (1), 28-39, 2011 | 129 | 2011 |
| Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis E Ormondroyd, L Donnelly, C Moynihan, C Savona, E Bancroft, DG Evans, ... European Journal of Human Genetics 20 (1), 4-10, 2012 | 113 | 2012 |
| Overexpression of RAD51 occurs in aggressive prostatic cancer A Mitra, C Jameson, Y Barbachano, L Sanchez, Z Kote‐Jarai, S Peock, ... Histopathology 55 (6), 696-704, 2009 | 112 | 2009 |
